Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Tablets: SOP for Reviewing Blending and Granulation Records – V 2.0

Posted on By

Tablets: SOP for Reviewing Blending and Granulation Records – V 2.0

Standard Operating Procedure for Reviewing Blending and Granulation Records

Department Tablet
SOP No. SOP/TAB/221/2025
Supersedes SOP/TAB/221/2022
Page No. Page 1 of 5
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

This SOP defines the procedure for reviewing blending and granulation records to ensure that the processes are carried out according to established specifications, regulatory requirements, and internal quality standards. The goal is to verify the consistency and quality of tablet batches.

2. Scope

This SOP applies to the review of all blending and granulation records for tablet manufacturing, covering both the R&D and production processes. It includes the documentation of materials used, process conditions, equipment parameters, and batch outcomes.

3. Responsibilities

  • Production Manager: Responsible for overseeing the blending and granulation processes and ensuring the records are accurately documented and complete.
  • Quality Control (QC) Team: Responsible for reviewing the blending and granulation records for compliance with specifications, identifying discrepancies, and recommending corrective actions if necessary.
  • Quality Assurance (QA) Manager: Responsible for approving the final review of blending and granulation records and ensuring compliance with regulatory requirements.
  • Regulatory Affairs Team: Ensures that the records meet all applicable regulatory standards and provides guidance on regulatory
requirements for record retention and review.

4. Accountability

The QA Manager is accountable for ensuring that blending and granulation records are properly reviewed and that any discrepancies or non-conformances are addressed. The Production and QC teams are responsible for ensuring that the records are complete and accurate.

5. Procedure

5.1 Record Review Process

  1. Collect all blending and granulation records for the batch being reviewed, including raw material logs, equipment settings, process conditions, and test results (Annexure-1).
  2. Verify that all necessary records are present and that all fields in the records are properly completed, including date, operator details, and equipment used.
  3. Ensure that the materials used for blending and granulation match the approved master batch record (MBR) and that they meet the required specifications (Annexure-2).

5.2 Verification of Process Parameters

  1. Verify that blending and granulation process parameters (e.g., mixing time, granulation fluid volume, speed, and temperature) are within the defined limits set in the MBR (Annexure-3).
  2. Check that equipment used for blending and granulation is properly calibrated and maintained. Ensure that any deviations from equipment specifications are documented and addressed.
  3. Review batch records for any deviations from established processes or specifications, and ensure that these deviations are investigated and resolved (Annexure-4).

5.3 Review of In-Process Testing

  1. Review in-process testing results, such as granule size distribution, moisture content, and density, to ensure that they meet the specified criteria (Annexure-5).
  2. If any testing results are out of specification (OOS), ensure that a thorough investigation is conducted, and corrective actions are implemented before proceeding with the batch (Annexure-6).
  3. Verify that all in-process test results are documented, and any OOS results are reviewed and approved by the appropriate personnel.

5.4 Approval and Final Review

  1. Once the blending and granulation records are reviewed and all criteria are met, the QA team shall approve the records (Annexure-7).
  2. In cases where discrepancies are identified, the QA team will work with the Production and QC teams to resolve the issue and re-verify the batch records before approval.
  3. Document the approval of the blending and granulation records in the appropriate review log.

5.5 Documentation and Record Keeping

  1. Ensure that all reviewed blending and granulation records are stored securely and are easily retrievable for future audits or inspections (Annexure-8).
  2. Maintain records for a minimum of 5 years, or as required by applicable regulations.
  3. Ensure that any deviations or discrepancies are properly documented and that corrective actions are followed up and tracked (Annexure-9).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • MBR: Master Batch Record
  • OOS: Out of Specification

7. Documents

  1. Blending and Granulation Batch Record (Annexure-1)
  2. Material Log (Annexure-2)
  3. Process Parameter Verification Sheet (Annexure-3)
  4. Deviation Report (Annexure-4)
  5. In-Process Testing Log (Annexure-5)
  6. OOS Investigation Report (Annexure-6)
  7. Final Approval Log (Annexure-7)
  8. Record Retention Log (Annexure-8)
  9. Corrective Action Log (Annexure-9)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • ISO 9001 – Quality Management Systems
  • GMP Guidelines for Pharmaceutical Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Blending and Granulation Batch Record

Batch Number Material Used Operator Date Process Parameter Result
Batch123 API, Excipients John Doe 01/03/2026 Mixing Speed 500 rpm

Annexure-2: Material Log

Material Batch Number Supplier Quantity
API Batch123 Supplier ABC 10 kg

Annexure-3: Process Parameter Verification Sheet

Parameter Specification Result Deviation Corrective Action
Mixing Speed 500 rpm 500 rpm None None

Annexure-4: Deviation Report

Deviation ID Description Action Taken Status
DEV001 Tablet hardness out of spec Reprocessed Resolved

Annexure-5: In-Process Testing Log

Test Specification Result Pass/Fail
Granule Size 100-250 µm 180 µm Pass

Annexure-6: OOS Investigation Report

OOS ID Issue Investigation Findings Action Taken
OOS001 Granulation moisture out of spec Inconsistent mixing Reprocessed with adjusted parameters

Annexure-7: Final Approval Log

Batch Number Approved By Approval Date
Batch123 John Smith 06/03/2026

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP creation New process QA Head
01/02/2025 2.0 Added in-process testing and documentation requirements Annual review QA Head
See also  Tablets: SOP for Investigating Tablet Coating Defects - V 2.0
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Capsule: SOP for Recordkeeping for Stability Studies of Capsules – V 2.0
Next Post: BA-BE Studies: SOP for Clinical Trial Budget Preparation and Approvals – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version